Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by de la Hera, M.
Right arrow Articles by Merino, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de la Hera, M.
Right arrow Articles by Merino, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol. 4, No. 1, pp. 67-74,January 1992
© 1992 Japanese Society for Immunology

Self-limited autoimmune disease related to transient donor B cell activation in mice neonatally injected with semi-allogeneic F1 cells

Marcial de la Hera1, Antonio de la Hera3, Angeles Ramos, Luis Buelta2, Jose Luis Alonso1, Vicente Rodriguez-Valverde1 and Jesus Merino

Immunology, Hospital‘Marqués de Valdecilla’, University of Cantabna Santander, Spain
1 Rheumatology, Hospital‘Marqués de Valdecilla’, University of Cantabna Santander, Spain
2 Pathology Units, Hospital‘Marqués de Valdecilla’, University of Cantabna Santander, Spain
3 The Basel Institute for Immunology, Grenzacherstrasse 487 Basel 4058, Switzerland

Correspondence to: Correspondence to: J. Merino

BALB/c mice injected at birth with 108 semi-allogeneic (C57BL/6 x BALB.IgHb)F1 spleen cells develop a lupus-like syndrome in which autoantibodles bear exclusively the donor allotype. We have analyzed the evolution of donor B cell chimerism and the autoimmune manifestations during the first year of life in these mice. Anti-DNA, -histone, and -cardiolipln IgG antibodies as well as circulating immune complexes appeared in the second week of life, reached the highest values around the sixth week, and then progressively dropped to normal values after the sixth month in most mice. The kinetics of the evolution of the autoimmune manifestations, as well as the kinetics of serum donor Ig allotype, were parallel to the kinetics of donor B cell chimerism, which was particularly prominent in the spleens in early weeks of life, and progressively decreased after remission of the autoimmune syndrome. Membrane-proliferative glomerulonephritls, which was followed as the more representative histological abnormality in this model, was particularly evident after 10 weeks of life, but disappeared by the end of the follow-up. Interestingly, when mice with a self-limited disease were re-injected with 108 F1 spleen cells i.v., a flare in the serologlcal manifestations was observed. In these re-injected mice a predominance of anti-DNA, lgG1 antibodies bearing exclusively the donor allotype was also observed, as in the early weeks of life. These results emphasize the central role of donor B cell chimerism in the development and in the self-limitation of the autoimmune disease in parental mice neonatally injected with F1 cells and Indicate that the capacity to react with F1 cells, to generate a renewed burst of symptoms, persists in these mice after the disappearance of autoimmune findings.

Keywords: neonatal tolerance, lupus-like syndrome, allogeneic interactions

Received 27 March 1991, accepted 1 August 1991.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
G. Foucras, C. Coureau, L. Beijleveld, P. Druet, A. Saoudi, and J.-C. Guery
{beta}2-Microglobulin-Dependent T Cells Are Not Necessary for Alloantigen-Induced Th2 Responses After Neonatal Induction of Lymphoid Chimerism in Mice
J. Immunol., August 15, 1998; 161(4): 1751 - 1757.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.